Published in J Med Virol on October 01, 1998
Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci U S A (1999) 2.22
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev (2001) 1.83
TT virus infection is widespread in the general populations from different geographic regions. J Clin Microbiol (1999) 1.45
Application of cation-coated filter method to detection of noroviruses, enteroviruses, adenoviruses, and torque teno viruses in the Tamagawa River in Japan. Appl Environ Microbiol (2005) 1.36
Nearly constant shedding of diverse enteric viruses by two healthy infants. J Clin Microbiol (2012) 1.27
Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. J Clin Microbiol (2007) 1.23
Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region. J Virol (2004) 1.04
Sequence heterogeneity of TT virus and closely related viruses. J Virol (2000) 1.04
High prevalence of TT virus DNA in human saliva and semen. J Clin Microbiol (2000) 0.99
Circular double-stranded forms of TT virus DNA in the liver. J Virol (2000) 0.98
Sequestration of TT virus of restricted genotypes in peripheral blood mononuclear cells. J Virol (2000) 0.97
Increased prevalence of anellovirus in pediatric patients with fever. PLoS One (2012) 0.96
Transfusion transmitted virus: A review on its molecular characteristics and role in medicine. World J Gastroenterol (2006) 0.96
Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection. J Virol (1999) 0.95
Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission. J Clin Microbiol (2000) 0.95
Torque teno virus: an improved indicator for viral pathogens in drinking waters. Virol J (2008) 0.94
Species-specific TT viruses and cross-species infection in nonhuman primates. J Virol (2000) 0.92
Transfusion-transmitted virus in association with hepatitis A-E viral infections in various forms of liver diseases in India. World J Gastroenterol (2006) 0.91
High frequencies of HGV and TTV infections in blood donors in Hangzhou. World J Gastroenterol (2001) 0.90
Geographic variation in the eukaryotic virome of human diarrhea. Virology (2014) 0.88
Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic. BMC Infect Dis (2004) 0.86
Histopathological investigation in porcine infected with torque teno sus virus type 2 by inoculation. Virol J (2011) 0.84
Molecular investigation of Torque teno sus virus in geographically distinct porcine breeding herds of Sichuan, China. Virol J (2013) 0.84
Prevalence of transfusion transmitted virus infection in hemodialysis patients and injection drug users compared to healthy blood donors in isfahan, iran. Gastroenterol Res Pract (2012) 0.82
TT viral infection through blood transfusion: retrospective investigation on patients in a prospective study of post-transfusion hepatitis. World J Gastroenterol (2000) 0.82
TT virus and hepatitis G virus infections in Korean blood donors and patients with chronic liver disease. World J Gastroenterol (2003) 0.81
Prevalence of Torque teno virus in healthy donors of Paraná State, southern Brazil. Rev Bras Hematol Hemoter (2015) 0.80
Investigation of HGV and TTV infection in sera and saliva from non-hepatitis patients with oral diseases. World J Gastroenterol (2002) 0.79
Detection of torque teno virus (TTV) in domestic village chickens in Iran. Vet Res Forum (2013) 0.79
Cloning and expression of N22 region of Torque Teno virus (TTV) genome and use of peptide in developing immunoassay for TTV antibodies. Virol J (2014) 0.77
Fecal excretion of a novel human circovirus, TT virus, in healthy children. Clin Diagn Lab Immunol (2000) 0.76
Prevalence and phylogenetic analysis of TT virus DNA in Western India. Clin Diagn Lab Immunol (2000) 0.75
Molecular characterization of human Torque Teno virus. Biomed Rep (2015) 0.75
Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J (1998) 6.94
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol (1992) 5.93
Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol (1988) 5.75
The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med (1990) 5.46
A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun (1997) 5.25
Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology (1992) 5.16
Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol (1991) 5.03
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem (2001) 4.51
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med (1991) 4.15
e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med (1976) 4.01
Cloning and sequencing of two tandem genes involved in degradation of 2,3-dihydroxybiphenyl to benzoic acid in the polychlorinated biphenyl-degrading soil bacterium Pseudomonas sp. strain KKS102. J Bacteriol (1989) 3.83
Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50
Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. J Antimicrob Chemother (1998) 3.41
Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med (1996) 3.13
Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl Environ Microbiol (1999) 3.06
Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J Biol Chem (1988) 3.05
Detection of Australia antigen by means of immune adherence haemagglutination test. Vox Sang (1971) 2.88
Hepatitis B e antigen and infectivity of hepatitis B virus. J Infect Dis (1977) 2.80
Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med (1990) 2.72
Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet (1981) 2.64
Accumulation of membrane glycoproteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail. J Cell Biol (1990) 2.57
Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol (1979) 2.56
A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology (1983) 2.49
Characterization of biphenyl catabolic genes of gram-positive polychlorinated biphenyl degrader Rhodococcus sp. strain RHA1. Appl Environ Microbiol (1995) 2.47
Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol (1994) 2.41
Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med (1994) 2.38
Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint. EMBO J (1998) 2.38
Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology (1992) 2.37
Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet (1990) 2.35
A Novel Transformation of Polychlorinated Biphenyls by Rhodococcus sp. Strain RHA1. Appl Environ Microbiol (1995) 2.35
Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol (1990) 2.30
Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia (1996) 2.22
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients. J Hepatol (1998) 2.21
Mmh/Ogg1 gene inactivation results in accumulation of 8-hydroxyguanine in mice. Proc Natl Acad Sci U S A (2000) 2.19
Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol (1994) 2.05
Molecular cloning of a Pseudomonas paucimobilis gene encoding a 17-kilodalton polypeptide that eliminates HCl molecules from gamma-hexachlorocyclohexane. J Bacteriol (1991) 2.03
Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation. Immunity (1998) 2.00
Three-dimensional structures of free form and two substrate complexes of an extradiol ring-cleavage type dioxygenase, the BphC enzyme from Pseudomonas sp. strain KKS102. J Mol Biol (1996) 1.98
Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med (1987) 1.93
FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res (2010) 1.92
Novel sulfated lymphocyte homing receptors and their control by a Core1 extension beta 1,3-N-acetylglucosaminyltransferase. Cell (2001) 1.90
A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology (1993) 1.90
Two co-existing mechanisms for nuclear import of MAP kinase: passive diffusion of a monomer and active transport of a dimer. EMBO J (1999) 1.90
Nuclear export of actin: a novel mechanism regulating the subcellular localization of a major cytoskeletal protein. EMBO J (1998) 1.89
The pathogenesis of experimental membranous glomerulonephritis induced with homologous nephritogenic tubular antigen. J Exp Med (1976) 1.87
The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity (2000) 1.83
Immunoglobulin G as possible precursor of chemotactic factor. Nature (1970) 1.82
Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol (1984) 1.82
Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A (1994) 1.81
Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology (1992) 1.81
Association between interleukin-18 gene polymorphism 105A/C and asthma. Clin Exp Allergy (2003) 1.80
Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood (1989) 1.80
Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. Proc Natl Acad Sci U S A (1992) 1.79
Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem (1987) 1.76
Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. J Biol Chem (1986) 1.74
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A (1986) 1.74
Identification of the bphA4 gene encoding ferredoxin reductase involved in biphenyl and polychlorinated biphenyl degradation in Pseudomonas sp. strain KKS102. J Bacteriol (1994) 1.74
Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol (1996) 1.72